Friday, November 21, 2008

Medical News Today News Alert

Dear Subscriber,

Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .


----------------------------------------------
** BREAST CANCER News **

Type Of Breast Reconstruction Impacts Radiation Therapy Outcomes
http://www.medicalnewstoday.com/articles/130275.php
For breast cancer patients who underwent a mastectomy who undergo radiation therapy after immediate breast reconstruction, autologous tissue reconstruction provides fewer long-term complications and better cosmetic results than tissue expander and implant reconstruction, according to a study in the November issue of the<i> International Journal of Radiation Oncology*Biology*Physics</i>, the official journal of the American Society for Therapeutic Radiology and Oncology.

----------------------------------------------
** CANCER / ONCOLOGY News **

Man Says His Dog Detected His Skin Cancer
http://www.medicalnewstoday.com/articles/130393.php
A man from Banbury near Oxford, England, said his dog sniffed out his skin cancer, reminiscent of reports of trials that have shown dogs can detect cancer, in some cases even when screening tests can't.

Scientists Honored For Contributions To Cancer Fight
http://www.medicalnewstoday.com/articles/130371.php
The American Cancer Society - the nation's leading voluntary health organization and largest non-governmental funder of cancer research and discovery - will present its highest honor, the Medal of Honor, to four Americans who have made outstanding contributions to the fight against cancer.

Tumors Fuelled By Lactic Acid
http://www.medicalnewstoday.com/articles/130327.php
A team of researchers at Duke University Medical Center and the Université catholique de Louvain (UCL) has found that lactic acid is an important energy source for tumor cells. In further experiments, they discovered a new way to destroy the most hard-to-kill, dangerous tumor cells by preventing them from delivering lactic acid.

Tumor Formation May Be Spurred By The Misreading Of Damaged DNA
http://www.medicalnewstoday.com/articles/130325.php
The DNA in our cells is constantly under assault from oxygen, the sun's radiation and environmental stresses. Most of the time, our cells can repair the damage before it gets copied into a permanent mutation that could lead to cancer.

Oral Gefitinib As Effective As Injected Docetaxel For Survival Of Patients With Non-Small-Cell Lung Cancer (Interest Study)
http://www.medicalnewstoday.com/articles/130288.php
Gefitnib is as effective a second-line treatment as docetaxel for patients with non-small cell* lung cancer. The INTEREST study, published in an Article in this week's edition of <i>The Lancet</i>, thus establishes gefitinib as a valid treatment option for people with this condition.

Pediatric Cancer : Alteration Of A Gene Causes Neuroblastoma
http://www.medicalnewstoday.com/articles/130248.php
Olivier Delattre's team (Inserm Unit 830 "Genetics and Biology of Cancer") of the Institut Curie reveal in an article in the 16 October issue of Nature that alteration of the ALK gene is closely associated with the most frequent solid extracerebral tumor in children neuroblastoma.

Ortho Biotech Announces NDA Submission For Trabectedin For The Treatment Of Relapsed Ovarian Cancer
http://www.medicalnewstoday.com/articles/130233.php
Ortho Biotech Products, L.P. announced the submission of a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for trabectedin when administered in combination with DOXIL(R) (doxorubicin HCI liposome injection)for the treatment of women with relapsed ovarian cancer (ROC).

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

'Urgent Need' For HPV Vaccine In Developing World, Opinion Piece Says
http://www.medicalnewstoday.com/articles/130338.php
<BR>While officials in the United Kingdom and the U.S. are "dithering and doubting" over issues related to <A href="http://www.gsk.com/" target=_new>GlaxoSmithKline</A> and <A href="http://www.

----------------------------------------------
** COLORECTAL CANCER News **

Painless, Non-Invasive And Inexpensive Test For Colon Cancer
http://www.medicalnewstoday.com/articles/130303.php
People are often reluctant to undergo a routine but painful colonoscopy - but the consequences can be fatal. According to the American Cancer Society, colon cancer is the third most common cancer found in American men and women and kills about 50,000 Americans every year.

----------------------------------------------
** LUNG CANCER News **

Oral Gefitinib As Effective As Injected Docetaxel For Survival Of Patients With Non-Small-Cell Lung Cancer (Interest Study)
http://www.medicalnewstoday.com/articles/130288.php
Gefitnib is as effective a second-line treatment as docetaxel for patients with non-small cell* lung cancer. The INTEREST study, published in an Article in this week's edition of <i>The Lancet</i>, thus establishes gefitinib as a valid treatment option for people with this condition.

Amgen, Takeda And Millennium Provide Update On Phase 3 Trial Of Motesanib In Patients With Non Small Cell Lung Cancer
http://www.medicalnewstoday.com/articles/130250.php
Amgen (Nasdaq: AMGN) and Millennium: The Takeda Oncology Company, a subsidiary of Takeda Pharmaceutical Company Limited (TSE: 4052), announced that enrollment in the Phase 3 MONET1 trial evaluating motesanib (AMG 706) in combination with paclitaxel and carboplatin for the first-line treatment of advanced non-small cell lung cancer (NSCLC) has been temporarily suspended following a planned safety data review of 600 patients by the study's independent Data Monitoring Committee (DMC).

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

No news for this category today.

-------------------------------------------------------------

You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

No comments: